跳至主要内容
临床试验/CTRI/2022/06/043506
CTRI/2022/06/043506尚未招募2 期

Efficacy of individualized homoeopathic medicines in Q-potency in treatment of lumbar spondylosis: a double-blind, randomized, placebo-controlled, clinical trial

The Calcutta Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with radiological diagnosis of lumbar spondylosis (2022 ICD-10-CM Diagnosis
  • Code M47.816) Spondylosis w/o myelopathy or radiculopathy, lumbar region
  • 2. Patients who have not taken any treatment since at least 2 weeks for lumbar spondylosis.
  • 3. Literate patients; can read Bengali and/or English
  • 4. Providing written informed consent to participate in the trial

排除标准

  • 1. Patients suffering from severe degenerative changes as found in radiological findings of lumbar
  • spondylosis.
  • 2. Patients having major life threatening disorder associated with lumbar spondylosis
  • 3. Other uncontrolled or unstable systemic or psychiatric diseases and/or infections affecting quality
  • 4. Patients who are too sick for consultation.
  • 5. Pregnant and puerperal women, and lactating mothers.
  • 6. Substance abuse and/or dependence
  • 7. Self-reported immune-compromised state
  • 8. Undergoing homoeopathic treatment for any chronic disease within last 6 months.

研究者

发起方
The Calcutta Homoeopathic Medical College and Hospital

相似试验